This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Aortic stenosis (valvular)

Authoring team

Valvular aortic stenosis can be congenital or acquired. There is often calcium deposition.

NICE guidance states (1):

Consider referring adults with asymptomatic severe aortic stenosis for intervention, if suitable, if they have any of the following:

  • Vmax (peak aortic jet velocity) more than 5 m/s on echocardiography
  • aortic valve area less than 0.6 cm2 on echocardiography
  • left ventricular ejection fraction (LVEF) less than 55%
  • B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP) level more than twice the upper limit of normal
  • symptoms unmasked on exercise testing.

Consider referring adults with symptomatic low-gradient aortic stenosis with LVEF less than 50% for intervention if during dobutamine stress echocardiography the aortic stenosis is shown to be severe by:

  • a mean gradient across the aortic valve that increases to more than 40 mmHg and
  • an aortic valve area that remains less than 1 cm2.

Consider measuring aortic valve calcium score on cardiac CT if the severity of symptomatic aortic stenosis is uncertain.

Offer enhanced follow up (for example, more frequent reviews) and further assessment (for example, stress echocardiography) to monitor the need for intervention if mid-wall fibrosis is detected on cardiac MRI in adults with severe aortic stenosis.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.